Waystar (WAY) – Research Analysts’ Recent Ratings Updates

Waystar (NASDAQ: WAY) has recently received a number of price target changes and ratings updates:

• 5/24/2026 – Waystar was downgraded by Wall Street Zen from “buy” to “hold”.
• 5/20/2026 – Waystar had its price target lowered by Barclays PLC from $36.00 to $25.00. They now have an “overweight” rating on the stock.
• 5/20/2026 – Waystar had its price target lowered by Barclays PLC from $36.00 to $25.00. They now have an “overweight” rating on the stock.
• 5/16/2026 – Waystar was upgraded by Wall Street Zen from “hold” to “buy”.
• 5/5/2026 – Waystar had its price target lowered by Citigroup Inc. from $35.00 to $30.00. They now have a “buy” rating on the stock.
• 5/4/2026 – Waystar was upgraded by Weiss Ratings from “sell (d+)” to “hold (c-)”.
• 4/30/2026 – Waystar had its “strong-buy” rating reaffirmed by Raymond James Financial, Inc.. They now have a $32.00 price target on the stock.
• 4/30/2026 – Waystar had its price target lowered by UBS Group AG from $41.00 to $37.00. They now have a “buy” rating on the stock.
• 4/30/2026 – Waystar had its price target lowered by JPMorgan Chase & Co. from $40.00 to $38.00. They now have an “overweight” rating on the stock.
• 4/30/2026 – Waystar had its “buy” rating reaffirmed by Needham & Company LLC. They now have a $33.00 price target on the stock.
• 4/10/2026 – Waystar had its price target lowered by Bank of America Corporation from $45.00 to $38.00. They now have a “buy” rating on the stock.
• 3/30/2026 – Waystar is now covered by Morgan Stanley. They set an “equal weight” rating and a $28.00 price target on the stock.

Waystar (NASDAQ:WAY) is a leading provider of cloud-based revenue cycle management and payment solutions for healthcare organizations. The company’s unified platform streamlines the entire financial continuum of patient care, from eligibility verification and claim submission to payment reconciliation and patient billing. By automating key processes and improving claim accuracy, Waystar helps providers reduce administrative overhead, accelerate cash flow and enhance overall revenue performance.

At the core of Waystar’s offering is a SaaS-based architecture that integrates seamlessly with existing electronic health record (EHR) systems and payer networks.